86923538 - Z

Information

  • Trademark
  • 86923538
  • Serial Number
    86923538
  • Registration Number
    5324651
  • Filing Date
    February 29, 2016
    8 years ago
  • Registration Date
    October 31, 2017
    7 years ago
  • Transaction Date
    October 06, 2023
    a year ago
  • Status Date
    October 05, 2023
    a year ago
  • Published for Opposition Date
    January 03, 2017
    7 years ago
  • Location Date
    October 05, 2023
    a year ago
  • First Use Anywhere Date
    June 22, 2015
    9 years ago
  • First Use In Commerce Date
    March 31, 2016
    8 years ago
  • Status Code
    701
  • Current Location
    TMO LAW OFFICE 111
    Employee Name
    FOSDICK, GEOFFREY A
  • Law Office Assigned Location Code
    M20
  • Owners
Mark Drawing Code
3000
Mark Identification
Z
Case File Statements
  • DM0000: The mark consists of a orange colored shield with the letter "Z" included in the shield in white.
  • CC0000: The color(s) orange, and white is/are claimed as a feature of the mark.
  • GS0421: Bacteriological consultation and research; Bacteriological research; Bacteriological research and testing; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical, biochemical, biological and bacteriological research and analysis; Compiling data for research purposes in the field of medical science and medical consultancy; Conducting clinical trials for others in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Custom design and development of chemical reagents and biochemical assays; Design and testing of new products for others; Development of pharmaceutical preparations and medicines; Diagnostic services in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Drug discovery services; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genotyping services for research or analysis purposes; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Medical and scientific research information in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Medical and scientific research, namely, conducting clinical trials for others; Medical research; Medical research services in the field of cancer; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research and development; Scientific research consulting in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of oncology; Scientific study and research in the field(s) of rheumatoid arthritis; Scientific study and research in the field(s) of diabetes; Scientific study and research in the field(s) of metabolic disorders; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies
Case File Event Statements
  • 10/5/2023 - a year ago
    29 - NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Type: NAS8
  • 10/5/2023 - a year ago
    28 - REGISTERED - SEC. 8 (6-YR) ACCEPTED Type: 8.OK
  • 10/5/2023 - a year ago
    27 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 5/26/2023 - a year ago
    26 - TEAS SECTION 8 RECEIVED Type: ES8R
  • 10/31/2022 - 2 years ago
    25 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 10/31/2017 - 7 years ago
    24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/27/2017 - 7 years ago
    23 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 9/26/2017 - 7 years ago
    22 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 9/20/2017 - 7 years ago
    21 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 8/28/2017 - 7 years ago
    20 - USE AMENDMENT FILED Type: IUAF
  • 9/14/2017 - 7 years ago
    19 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 8/28/2017 - 7 years ago
    18 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 2/28/2017 - 7 years ago
    17 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 1/3/2017 - 7 years ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/3/2017 - 7 years ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/14/2016 - 8 years ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/29/2016 - 8 years ago
    13 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 11/23/2016 - 8 years ago
    12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/22/2016 - 8 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/22/2016 - 8 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/8/2016 - 8 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 10/28/2016 - 8 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/10/2016 - 8 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/10/2016 - 8 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/10/2016 - 8 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/10/2016 - 8 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/4/2016 - 8 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 3/3/2016 - 8 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/3/2016 - 8 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP